Neuraxis, Inc. (NRXS)
NYSE: NRXS · Electromedical & Electrotherapeutic Apparatus · Carmel, IN · filing with the SEC since 2022
Who owns Neuraxis, Inc.
As filed with the SECHolders of 5% or more
2
Brian P. Hannasch holds 12% of Common Stock, $0.001 par value per share, as its SCHEDULE 13G/A filed Jul 2, 2025 says.
Directors and officers
9
report now, of 13 people on the record since 2023. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Brian P. Hannasch
SCHEDULE 13G/A · filed Jul 2, 2025 · Common Stock, $0.001 par value per share · 7.5% in Jul 1, 2025
Bigger Michael
SCHEDULE 13G/A · filed Aug 3, 2026 · Common Stock, par value $0.001 per share · 6.64% in May 1, 2026
What NRXS reports owning in othersstakes of 5% or more, and other ties
Neuraxis, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
7purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$1.1Mbought, in dollars
Open-market trades on Form 4 from Oct 8, 2025 to Oct 8, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 8, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Carrico Brian Allen | Chief Executive Officer | 0 | $0 | 0 | 2 | $0 |
| Henrichs Timothy Robert | Chief Financial Officer | 0 | $0 | 0 | 2 | $0 |
| Carrico Thomas Joeseph | CRO, CCO, CPO | 0 | $0 | 0 | 2 | $0 |
| Hannasch Brian | 10% owner | 0 | $0 | 0 | 2 | $400,000 |
| Aharon Gil | director | 0 | $0 | 0 | 1 | $1.0M |